Zhou Dong, Zhou Haibing, Jenks Carl C, Lewis Jason S, Katzenellenbogen John A, Welch Michael J
Mallinckrodt Institute of Radiology, Washington University School of Medicine, St. Louis, Missouri 63110, USA.
Bioconjug Chem. 2009 Apr;20(4):808-16. doi: 10.1021/bc800313c.
No-carrier-added (NCA) (76)Br labeling of 4-(5-acetoxy-7-bromobenzoxazol-2-yl)phenyl acetate, a diacetate-protected estrogen-receptor beta (ERbeta) selective ligand, was carried out successfully using [(76)Br]bromide ion. The labeling was achieved via oxidative electrophilic destannylation of an organotin precursor molecule by modification of the leaving group (from Bu(3)Sn to Me(3)Sn) and the addition of methanol to the reaction mixture. The differences between the oxidative bromination reaction under small-scale macroscopic vs tracer level radiochemical conditions were explored in terms of effective brominating agents, which depend greatly on the nature of the solvent during the radiochemical bromination, and the potential interference by trace levels of highly reactive impurities in the reaction that compete for the desired bromination at the NCA level. Our observations, and our development of experimental protocols for successful radiobromination at the tracer NCA-scale, should be applicable to the synthesis of other radiobromine-labeled organic compounds of potential interest as PET radiopharmaceuticals and radiotherapy agents.
使用[(76)Br]溴离子成功实现了对4-(5-乙酰氧基-7-溴苯并恶唑-2-基)苯基乙酸酯(一种二乙酸酯保护的雌激素受体β(ERβ)选择性配体)的无载体添加(NCA)(76)Br标记。通过修饰离去基团(从Bu(3)Sn变为Me(3)Sn)并向反应混合物中添加甲醇,经由有机锡前体分子的氧化亲电脱锡反应实现了标记。从小规模宏观与示踪剂水平放射化学条件下的氧化溴化反应差异方面,探讨了有效的溴化剂,其在很大程度上取决于放射化学溴化过程中的溶剂性质,以及反应中痕量高活性杂质在NCA水平上对所需溴化反应的潜在干扰。我们的观察结果以及我们开发的用于在示踪剂NCA规模上成功进行放射性溴化的实验方案,应适用于合成其他作为PET放射性药物和放射治疗剂可能具有潜在兴趣的放射性溴标记有机化合物。